Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Discovery Therapeutic's N-0923 trial results to be presented

June 21, 1996

Peptides resembling h-MBP claimed

June 21, 1996

COMT inhibitor disclosed by Roche

June 21, 1996

Taro's anticonvulsant drug undergoes development

June 21, 1996

Pierre Fabre describes 5-HT1 receptor ligands

June 21, 1996

FDA approves Organon's Remeron

June 21, 1996

RPR describes RPR-107880 synthesis

June 21, 1996

Cypros conferred SBIR grant to develop CPC-111 prodrugs

June 14, 1996

Activase cleared by FDA for ischemic stroke

June 14, 1996

More glutamate antagonists from NeuroSearch

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 7, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 7, 2025
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...
Radiopharma Advancell raises $112M in series C for alpha therapies
BioWorld
Aussie radiopharma company Advancell Co. Ltd. closed an oversubscribed $112 million series C round that will accelerate clinical development of its pipeline of...